PEPTIDES BIO / QUALITY & DOCUMENTATION
CJC-1295 and Ipamorelin: A Material-Identity Guide
Research guidance for CJC-1295 and Ipamorelin materials, including component identity, DAC terminology, source review, and documentation boundaries.
Research or raw-material evaluation only. Not for human or veterinary use.
The first decision in a CJC-1295 and Ipamorelin enquiry is which material the project actually requires. This catalogue includes CJC-1295 with DAC, CJC-1295 without DAC, Ipamorelin as a single material, and a CJC-1295 (No DAC) / Ipamorelin 5 mg / 5 mg blend. The published experiments below examined individual research compounds; they help frame a project, but they are not results from the offered two-component blend.
Four names that should not be collapsed into one result
| Catalogue choice | What the name tells you | Relevant page |
|---|---|---|
| CJC-1295 with DAC | Distinct albumin-binding analogue in the cited CJC-1295 study. | With-DAC 5 mg |
| CJC-1295 without DAC | A separately named CJC-1295 catalogue material; do not import the with-DAC half-life result. | No-DAC 5 mg |
| Ipamorelin | A pentapeptide studied separately in pituitary-cell and animal research. | Ipamorelin 5 mg |
| No-DAC / Ipamorelin blend | Two labelled 5 mg components in one catalogue item. | Blend 5 mg / 5 mg |
What the cited experiments measured
In a rat study of the with-DAC CJC-1295 analogue, the authors reported approximately fourfold greater growth-hormone area under the curve over two hours than their hGRF(1–29) comparator; the compound was detected in plasma beyond 72 hours. The albumin-binding design is part of that result. Read the CJC-1295 study.
In the separate original Ipamorelin study, primary rat pituitary cells released growth hormone with a reported EC50 of 1.3 ± 0.4 nmol/L, compared with 2.2 ± 0.3 nmol/L for GHRP-6 under that assay. Those figures describe the study’s single-compound comparison, not a blend test. Read the Ipamorelin study.
Choose a material that matches the question
If your project is about the albumin-binding CJC-1295 literature, start with the with-DAC identity. If it needs a no-DAC catalogue item or Ipamorelin alone, name that item explicitly. If a two-component format is required, the 5 mg / 5 mg blend gives the team a clear product reference for pricing and documentation. A published result for either component is background for research planning; the proposed combination endpoint still needs its own study design.
Ask for a quote or product documentation with the exact format, component names and research question. This material is offered for research use.
References
Need a product record?